Pubdiz
Taipei Medical University

Pubdiz from Gene to Disease ��] ��Ʈw

A B C D E F G H I J K L M N O P Q R X Y Z



Gene Symbol
Gene NameAliasesPrevious_Symbol

APP

amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease)


Gene APP gene interaction
View Neighborhood Gene

Result number fewer <<<< << < ALL > >> >>> more

MeSH term
FrequencyCondition_Probility

Adult

330.0

Age of Onset

40.0

Alzheimer Disease/*genetics

185.0

Genetic Predisposition to Disease/*genetics

20.0

Humans

2290.0

Male

540.0

Membrane Proteins/*genetics

121.0

*Mutation

60.0

Pedigree

80.0

Research Support, Non-U.S. Gov't

1550.0

Alzheimer Disease/*metabolism

178.0

Amyloid beta-Protein Precursor/*metabolism

2029.0

Blotting, Northern

50.0

Cell Nucleus/metabolism

40.0

Cells, Cultured

180.0

Immunohistochemistry

200.0

Plasmids/metabolism

50.0

RNA/metabolism

20.0

Reverse Transcriptase Polymerase Chain Reaction

20.0

Time Factors

100.0

*Trans-Activation (Genetics)

20.0

Transfection

240.0

Binding Sites

130.0

Endopeptidases/*metabolism

86.0

Kinetics

230.0

Models, Molecular

20.0

Recombinant Proteins/antagonists & inhibitors

24.0

Amyloid beta-Protein/metabolism

815.0

Animals

1060.0

COS Cells

20.0

Cell Line

250.0

Cytoplasm/metabolism

60.0

Mice

390.0

Precipitin Tests

40.0

Protein Binding

160.0

Protein Isoforms

20.0

Protein Structure, Tertiary

90.0

Signal Transduction

60.0

Tumor Cells, Cultured

110.0

Amino Acid Motifs

20.0

Amino Acid Sequence

290.0

Comparative Study

310.0

Female

510.0

Membrane Proteins/genetics/*metabolism

31.0

Nerve Tissue Proteins/genetics/*metabolism

42.0

Research Support, U.S. Gov't, P.H.S.

800.0

Aged

470.0

Angiotensin-Converting Enzyme Inhibitors/*adverse effects

24.0

Middle Aged

430.0

Amyloid beta-Protein/*biosynthesis

541.0

Nerve Tissue Proteins/*biosynthesis

39.0

Polymerase Chain Reaction

90.0

RNA, Messenger/analysis

70.0

Mice, Knockout

50.0

Molecular Sequence Data

410.0

Apolipoproteins E/genetics

92.0

Chromosome Mapping

50.0

Genetic Markers

40.0

Genotype

80.0

Linkage (Genetics)

30.0

Neuropsychological Tests

31.0

Tomography, X-Ray Computed

20.0

Amyloid beta-Protein Precursor/*chemistry

350.0

Cytoplasm/chemistry

21.0

DNA, Complementary/metabolism

20.0

Models, Biological

70.0

Rats

240.0

Alzheimer Disease/metabolism

812.0

Caenorhabditis elegans

22.0

Drosophila

20.0

Mutagenesis, Site-Directed

30.0

Sequence Homology, Amino Acid

130.0

Species Specificity

60.0

Structure-Activity Relationship

40.0

Aged, 80 and over

130.0

Multigene Family

30.0

Amyloid beta-Protein/biosynthesis

342.0

Amyloid beta-Protein Precursor/genetics

1020.0

Membrane Proteins/genetics

102.0

Mutation

190.0

Macromolecular Substances

20.0

Sequence Deletion

20.0

Amyloid beta-Protein Precursor/genetics/metabolism

535.0

Endopeptidases/metabolism

96.0

Membrane Proteins/*metabolism

40.0

Alzheimer Disease/*drug therapy/*genetics

250.0

Age Factors

30.0

Alzheimer Disease/genetics/*metabolism

310.0

Amyloid beta-Protein Precursor/*genetics

1930.0

Blood-Brain Barrier/*physiology

37.0

Disease Models, Animal

90.0

Mice, Inbred C57BL

50.0

Mice, Transgenic

180.0

Rats, Sprague-Dawley

60.0

PC12 Cells

41.0

*Protein Processing, Post-Translational

20.0

Amyloid beta-Protein/*metabolism

33.0

Endopeptidases/*physiology

214.0

Neurons/metabolism

51.0

Predictive Value of Tests

20.0

Amyloid beta-Protein Precursor/chemistry/*metabolism

330.0

Glycosylation

40.0

Protein Kinase C/metabolism

40.0

Protein Processing, Post-Translational

91.0

Apoptosis

20.0

Inflammation

20.0

Amyloid beta-Protein Precursor/genetics/*metabolism

932.0

Gene Expression

30.0

Half-Life

20.0

Lysine Carboxypeptidase/metabolism

2100.0

Metalloendopeptidases/blood

228.0

Blotting, Western

140.0

Brain Chemistry/genetics

24.0

Case-Control Studies

30.0

Cerebral Cortex/*metabolism

35.0

Gene Expression Regulation

40.0

In Vitro

110.0

Nerve Tissue Proteins/*metabolism

72.0

Apolipoproteins E/*genetics

50.0

English Abstract

130.0

Polymorphism, Genetic

20.0

Enzyme Inhibitors/pharmacology

40.0

Plasmids/genetics

20.0

Recombinant Proteins/pharmacology

40.0

Carrier Proteins/metabolism

30.0

Acute-Phase Proteins/metabolism

34.0

Adolescent

70.0

Analysis of Variance

20.0

Chi-Square Distribution

20.0

Child

50.0

Child, Preschool

30.0

Infant

30.0

Magnetic Resonance Imaging

20.0

Polymorphism, Restriction Fragment Length

20.0

Amyloid beta-Protein Precursor/isolation & purification/*metabolism

2100.0

Binding, Competitive

20.0

Brain/metabolism

60.0

CHO Cells

70.0

Carrier Proteins/isolation & purification/*metabolism

26.0

Gene Library

20.0

Hamsters

80.0

Neurons/*metabolism

51.0

Membrane Proteins/genetics/metabolism

21.0

Mutation/genetics

50.0

Alzheimer Disease/*metabolism/pathology

55.0

Amyloid beta-Protein/genetics/*metabolism

218.0

Cell Death

20.0

Disease Progression

30.0

Hippocampus/metabolism/pathology

310.0

Research Support, U.S. Gov't, Non-P.H.S.

50.0

Acute-Phase Proteins/*metabolism

47.0

Prospective Studies

70.0

Amyloid beta-Protein Precursor/metabolism

720.0

Point Mutation/genetics

20.0

Membrane Proteins/*physiology

21.0

Recombinant Proteins/metabolism

50.0

Peptide Fragments/metabolism

71.0

Amyloid beta-Protein Precursor/*genetics/*metabolism

250.0

Brain Chemistry/*genetics

24.0

Electrophoresis, Polyacrylamide Gel

70.0

*Peptides

23.0

*Plant Proteins

23.0

Genetic Predisposition to Disease

30.0

Membrane Proteins/metabolism

40.0

Phenotype

30.0

DNA Probes

30.0

Embryo

30.0

LDL-Receptor Related Protein 1

21.0

Guinea Pigs

20.0

Membranes, Artificial

22.0

Reference Values

50.0

alpha 1-Antitrypsin/biosynthesis

225.0

Risk Factors

60.0

Biotinylation

21.0

Enzyme-Linked Immunosorbent Assay

60.0

Amyloid beta-Protein Precursor/*genetics/metabolism

360.0

Apolipoproteins E/metabolism

23.0

Nuclear Proteins/*metabolism

71.0

Microsomes, Liver/*metabolism

21.0

Dose-Response Relationship, Drug

40.0

Hydrogen-Ion Concentration

20.0

Temperature

20.0

Antiplasmin/analysis

25.0

Antithrombin III/analysis

21.0

Biological Markers/blood

20.0

Peptide Hydrolases/analysis

21.0

Plasmin/analysis

24.0

Statistics, Nonparametric

20.0

Acute-Phase Proteins/*biosynthesis

731.0

Fibrinogen/biosynthesis

436.0

Haptoglobins/biosynthesis

233.0

Leucine/metabolism

23.0

Peptide Hydrolases/*metabolism

22.0

Adenoviridae/genetics

20.0

Astrocytes/metabolism

22.0

Cerebral Cortex/metabolism

23.0

Immunoblotting

70.0

Drug Design

30.0

Molecular Structure

30.0

Treatment Outcome

20.0

Alternative Splicing

30.0

Molecular Weight

90.0

Sequence Alignment

30.0

Tissue Distribution

40.0

Base Sequence

180.0

Cloning, Molecular

50.0

Phosphorylation

30.0

Homeostasis

20.0

Acute-Phase Proteins/*analysis

56.0

C-Reactive Protein/analysis

101.0

Interleukin-6/*blood

31.0

Orosomucoid/analysis

48.0

Mutation, Missense/*genetics

21.0

Severity of Illness Index

50.0

Cattle

60.0

Frontal Lobe/*metabolism

222.0

Blood Platelets/drug effects/*metabolism

22.0

Calcium/metabolism

20.0

Thrombin/pharmacology

20.0

Liver/*metabolism

30.0

Hela Cells

60.0

Nerve Tissue Proteins/metabolism

20.0

Amyloid beta-Protein Precursor/*chemistry/metabolism

480.0

Microscopy, Electron

40.0

Protein Conformation

40.0

Chromatography, Affinity

50.0

Fibroblasts

20.0

Trypsin/metabolism

21.0

Biological Transport

20.0

Brain/*metabolism

51.0

Chromosomes, Human, Pair 21

32.0

Brain/metabolism/pathology

21.0

Genetic Vectors

30.0

Peptide Fragments/genetics/metabolism

21.0

Culture Media, Conditioned

20.0

Neuroblastoma

21.0

Alzheimer Disease/genetics/metabolism

330.0

Cell Survival/drug effects

20.0

Heparin/*metabolism

33.0

Chromatography, Gel

20.0

Dimerization

20.0

Interleukin-1/pharmacology

40.0

Interleukin-6/pharmacology

20.0

*Gene Expression Regulation

30.0

Models, Genetic

20.0

Carcinoma, Hepatocellular/metabolism

33.0

Cell Line, Tumor

30.0

Dexamethasone/pharmacology

20.0

Receptors, Interleukin-1/antagonists & inhibitors

23.0

Solubility

50.0

Tumor Necrosis Factor-alpha/pharmacology

20.0

Acute-Phase Proteins/physiology

233.0

Cytokines/physiology

21.0

Signal Transduction/*physiology

20.0

Cercopithecus aethiops

20.0

DNA Primers

40.0

DNA, Complementary

30.0

Blood Sedimentation

42.0

Promoter Regions (Genetics)

30.0

Transcription Factors/*metabolism

20.0

Transcription, Genetic

30.0

Oligodeoxyribonucleotides

40.0

Restriction Mapping

40.0

*Promoter Regions (Genetics)

30.0

Brain Chemistry

20.0

Conserved Sequence

20.0

Rats, Wistar

20.0

Zinc/*metabolism

23.0

*Blood Coagulation

20.0

*Fibrinolysis

21.0

Acute Disease

20.0

Amyloid beta-Protein Precursor/biosynthesis/genetics

240.0

*Chromosomes, Human, Pair 21

31.0

Blood Proteins/metabolism

20.0

Interleukin-6/blood

30.0

Tumor Necrosis Factor-alpha/analysis

20.0

Amyloid beta-Protein Precursor/*blood

2100.0

Blood Platelets/*chemistry

38.0

Ubiquitins/*metabolism

21.0

Lod Score

20.0

Molecular Conformation

31.0

Sequence Homology, Nucleic Acid

30.0

Trans-Activation (Genetics)

30.0

Transcription, Genetic/drug effects

20.0

Brain/pathology

30.0

Autoradiography

30.0

Histocytochemistry

20.0

In Situ Hybridization

30.0

RNA, Messenger/*metabolism

20.0

Golgi Apparatus/metabolism

21.0

Organ Specificity

20.0

Mice, Inbred BALB C

20.0

*Chromosome Mapping

20.0

Crosses, Genetic

20.0

Hybrid Cells

20.0

*Genetic Markers

20.0

Exons

20.0

Double-Blind Method

20.0

Infant, Newborn

30.0

Amyloid beta-Protein Precursor/*biosynthesis

233.0

Substrate Specificity

60.0

Nucleic Acid Hybridization

40.0

Immunoenzyme Techniques

20.0

Antibodies, Monoclonal

20.0

Amyloid beta-Protein Precursor

1173.0

Liver/metabolism

20.0

Placenta/enzymology

22.0

Pregnancy

30.0

Pyridines/*metabolism

220.0

Amyloid/*genetics

38.0

*Brain Chemistry

21.0

*Gene Expression

20.0

*Protease Inhibitors

327.0

Protein Precursors/*genetics

32.0

alpha 1-Antichymotrypsin/*blood

222.0

DNA Mutational Analysis

30.0

Microscopy, Fluorescence

20.0

Genes, Dominant/genetics

21.0

Fibrinogen/analysis

21.0

alpha 1-Antitrypsin/analysis

22.0

Brain/*pathology

21.0

Microscopy, Immunoelectron

20.0

Gene Frequency

20.0

Heterozygote

20.0

Protease Inhibitors/pharmacology/therapeutic use

250.0

tau Proteins/genetics

228.0